Overview
GENB market data
Price History
GENB price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for GENB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Cathie Wood Likes That New Stock Smell: 3 IPO Stocks She Bought on MondayThe Motley Fool · Jul 7, 2026, 4:15 PM
Nike, Shutterstock And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Jul 1, 2026, 12:05 PM
A Deep Dive Into Nvidia’s Latest Portfolio MovesInvesting.com · May 20, 2026, 1:15 PM
Generate Biomedicines shares are trading higher after a 13F filing revealed NVIDIA took a new 833,325-share stake.Benzinga · May 15, 2026, 8:26 PM
NVIDIA Corporation Increases Stake In CoreWeave To 47,213,353 Shares, Maintains Holdings In Intel Corporation (214,776,632 Shares), Nebius Group N.V. (1,190,476 Shares), Nokia Corporation (166,389,351 Shares), Synopsys (4,821,717 Shares), Takes New Stakes In Coherent Corp. (7,788,161 Shares) Generate Biomedicines (833,325 Shares).Benzinga · May 15, 2026, 8:24 PM
Nvidia Takes New Stake In Generate Biomedicines With 833,325 SharesBenzinga · May 15, 2026, 8:19 PM
Morgan Stanley Maintains Overweight on Generate Biomedicines, Raises Price Target to $22Benzinga · May 14, 2026, 5:15 PM